Summary
Background
Heat shock protein 70 is a molecular chaperone important in host responses to stress, including infection, injury, oxidative damage, hypoxia, and thermal stress. This study analyzed the correlation between preoperative serum concentrations of anti-HPS70 antibody and postoperative morbidity in patients with esophageal cancer.
Materials and methods
Serum samples were obtained preoperatively from 50 esophageal carcinoma patients (46 men and 4 women) who underwent potentially curative surgery without preoperative therapy. Serum anti-HSP70 antibody concentrations were measured by enzyme-linked immunosorbent assays.
Results
The mean concentration of anti-HSP70 antibody was 187.0 μg/mL. When patients were dichotomized relative to this cutoff, we observed no significant relationships between perioperative inflammatory markers (maximum body temperature, white blood cell count and C-reactive protein concentration) and anti-HSP70 antibody concentration. The incidence of postoperative complications was significantly lower in patients with anti-HSP ≥ 187.0 μg/mL than < 187.0 μg/mL (p = 0.0336).
Conclusions
Preoperative serum concentration of anti-HSP70 antibody was significantly related to postoperative morbidities in patients with esophageal cancer.
Similar content being viewed by others
References
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN. 2008. Int J Cancer. 2010;127(12):2893–917.
Sharaiha RZ, Halazun KJ, Mirza F, et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol. 2011;18(12):3362–9.
Biere SS, Maas KW, Cuesta MA, van der Peet DL. Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis. Dig Surg. 2011;28(1):29–35.
Glatz T, Marjanovic G, Zirlik K, et al. Surgical treatment of esophageal cancer: evolution of management and prognosis over the last 3 decades. Chirurg. 2014 ([Epub ahead of print] German).
Benedix F, Dalicho SF, Stübs P, et al. Evidence base for minimally invasive esophagectomy for esophageal cancer. Chirurg. 2014;85(8):668–74 (German).
Hoeppner J, Marjanovic G, Glatz T, et al. Hybrid laparoscopic thoracotomic esophagectomy with intrathoracic esophagogastric anastomosis. Chirurg. 2014;85(7):628–35 (German).
Evans CG, Chang L, Gestwicki JE. Heat shock protein 70 (HSP70) as an emerging drug target. J Med Chem. 2010;53(12):4585–602.
Vega VL, Rodríguez-Silva M, Frey T, et al. HSP70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. J Immunol. 2008;180(6):4299–307.
Nakajima M, Kuwano H, Miyazaki T, Masuda N, Kato H. Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma. Cancer Lett. 2002;178(1):99–106.
Nakajima M, Kato H, Miyazaki T, et al. Tumor immune systems in esophageal cancer with special reference to heat-shock protein 70 and humoral immunity. Anticancer Res. 2009;29(5):1595–606.
Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, Kroemer G. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle. 2006;5(22):2592–601.
Jäättelä M, Wissing D. Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection. J Exp Med. 1993;177(1):231–6.
De Maio A. Heat shock proteins: facts, thoughts, and dreams. Shock. 1999;11(1):1–12.
Ran R, Lu A, Zhang L, et al. HSP70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling. Genes Dev. 2004;18(12):1466–81.
Park KJ, Gaynor RB, Kwak YT. Heat shock protein 27 association with the I kappa B kinase complex regulates tumor necrosis factor alpha-induced NF-kappa B activation. J Biol Chem. 2003;278(37):35272–8.
Saito K, Dai Y, Ohtsuka K. Enhanced expression of heat shock proteins in gradually dying cells and their release from necrotically dead cells. Exp Cell Res. 2005;310(1):229–36.
Clayton A, Turkes A, Navabi H, Manson MD, Tabi Z. Induction of heat shock proteins in B-cell exosomes. J Cell Sci. 2005;118(Pt 16):3631–8.
Asea A, Kraeft SK, Kurt-Jones EA, et al. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med. 2000;6(4):435–42.
Panjwani NN, Popova L, Srivastava PK. Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J Immunol. 2002;168(6):2997–3003.
Lehner T, Bergmeier LA, Wang Y, et al. Heat shock proteins generate beta-chemokines which function as innate adjuvants enhancing adaptive immunity. Eur J Immunol. 2000;30(2):594–603.
Pan PJ, Chan RC, Yang AH, Chou CL, Cheng YF, Chiu JL. Protective effects of preconditioned local somatothermal stimulation on neuromuscular plasticity against ischemia—reperfusion injury in rats. J Orthop Res. 2008;26(12):1670–4.
Jones Q, Voegeli TS, Li G, Chen Y, Currie RW. Heat shock proteins protect against ischemia and inflammation through multiple mechanisms. Inflamm Allergy Drug Targets. 2011;10(4):247–59.
St Rammos K, Koullias GJ, Hassan MO, et al. Low preoperative HSP70 atrial myocardial levels correlate significantly with high incidence of postoperative atrial fibrillation after cardiac surgery. Cardiovasc Surg. 2002; 10(3): 228–32.
Newkirk MM, Mitchell S, Procino M, et al. Chronic smoke exposure induces rheumatoid factor and anti-heat shock protein 70 autoantibodies in susceptible mice and humans with lung disease. Eur J Immunol. 2012;42(4):1051–61.
Helgeland G, Petzold A, Hoff JM, Gilhus NE, Plant GT, Romi FR. Anti-heat shock protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome. J Neuroimmunol. 2010;225(1–2):180–3.
Zhang X, Xu Z, Zhou L, et al. Plasma levels of HSP70 and anti-HSP70 antibody predict risk of acute coronary syndrome. Cell Stress Chaperones. 2010;15(5):675–86.
Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23):2241–52.
Biere SS, Maas KW, Cuesta MA, van der Peet DL. Cervical or thoracic anastomosis after esophagectomy for cancer: a systematic review and meta-analysis. Dig Surg. 2011;28(1):29–35.
Shiozaki A, Fujiwara H, Okamura H, et al. Risk factors for postoperative respiratory complications following esophageal cancer resection. Oncol Lett. 2012;3(4):907–12.
Aminian A, Panahi N, Mirsharifi R, et al. Predictors and outcome of cervical anastomotic leakage after esophageal cancer surgery. J Cancer Res Ther. 2011; 7(4): 448–53.
Radons J, Mulfhoff G. Immunostimulatory functions of membrane-bound and exported heat shock protein 70. Exerc Immunol Rev. 2005;11:17–33.
Michelet P, Journo XBD, Roch A, et al. Perioperative risk factors for anastomotic leakage after esophagectomy. Chest. 2005;128(5):3461–6.
Miyazaki T, Kuwano H, Kato H, Yoshikawa M, Ojima H, Tsukada K. Predictive value of blood flow in the gastric tube in anastomotic insufficiency after thoracic esophagectomy. World J Surg. 2002;26(11):1319–23.
Ikeda Y, Niimi M, Kan S, et al. Clinical significance of tissue blood flow during esophagectomy by laser Doppler flowmetry. J Thorac Cardiovasc Surg. 2001;122(6):1101–6.
Kimura Y, Yamada K, Sakai T, et al. The regulatory role of heat shock protein 70-reactive CD4 + T cells during rat listeriosis. Int Immunol. 1998;10(2):117–30.
Tanaka S, Kimura Y, Mitani A, et al. Activation of T cell recognizing an epitope of heat shock protein 70 can protect against rat adjuvant arthritis. J Immunol. 1999;163(10):5560–5.
Paliwal PK, Bansal A, Sagi SS, Sairam M. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection. Vaccine. 2011;29(38):6532–9.
Fujibayashi T, Hashimoto N, Jijiwa M, Hasegawa Y, Kojima T, Ishiguro N. Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model. BMC Pulm Med. 2009; 9: 45.
Yanaka A, Zhang S, Sato D, et al. Geranylgeranylacetone protects the human gastric mucosa from diclofenac-induced injury via induction of heat shock protein 70. Digestion. 2007;75(2–3):148–55.
Yu WY, Chuang TF, Guichard C, et al. Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model. Vaccine. 2011;29(18):3489–500.
Chen W, Lin Y, Liao C, Hsieh S. Modulatory effects of the human heat shock protein 70 on DNA vaccination. J Biomed Sci. 2000;7(5):412–9.
Acknowledgments
We thank Ms. Hitomi Ozeki, Ms. Yuki Ohashi, and Ms. Nozomi Yuzawa for their excellent secretarial assistance.
Ethical standard statement
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
Statement of informed consent
Informed consent was obtained from all patients for being included in the study.
Conflict of interest
Masanobu Nakajima, Hiroyuki Kato, Makoto Sakai, Akihiko Sano, Tatsuya Miyazaki, Makoto Sohda, Takanori Inose, Takehiko Yokobori, Naritaka Tanaka, Shigemasa Suzuki, Norihiro Masuda, Minoru Fukuchi, and Hiroyuki Kuwano declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakajima, M., Kato, H., Sakai, M. et al. Significant relationship between preoperative serum concentration of anti-heat shock protein 70 antibody and postoperative morbidity in patients with esophageal cancer. Eur Surg 47, 117–122 (2015). https://doi.org/10.1007/s10353-015-0317-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10353-015-0317-9